NLM Digital Collections

Search

Start Over Genre Technical Report ✖Remove constraint Genre: Technical Report Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

1441. Compounded drug products that are essentially copies of a commercially available drug product under Section 503A of the Federal Food, Drug, and Cosmetic Act

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, January 2018
Subject(s):
Drug Compounding -- standards
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.

1444. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents

Author(s):
Doshi, Jalpa A., author
Li, Pengxiang, author
Huo, Hairong, author
Pettit, Amy R., author
Armstrong, Katrina A., author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
Subject(s):
Antineoplastic Agents -- economics
Antineoplastic Agents -- therapeutic use
Drug Costs
Financing, Personal -- statistics & numerical data
Medication Adherence -- statistics & numerical data
Administration, Oral
Antineoplastic Agents -- administration & dosage
Health Services Accessibility
Prescription Drugs -- economics
Socioeconomic Factors
Time Factors
Humans
United States

1445. Show me the money: economic evaluations of opioid use disorder interventions

Author(s):
Murphy, Sean M., author
Polsky, Daniel, author
Meisel, Zachary, author
Mitchell, Julia, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2016
Subject(s):
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Buprenorphine -- therapeutic use
Cost-Benefit Analysis
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Reward
Humans
United States

1446. Primary care: on the front lines of the opioid epidemic

Author(s):
Bachhuber, Marcus A., author
Weiner, Janet, author
Mitchell, Julia, author
Samet, Jeffrey, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, August 2016
Subject(s):
Opioid-Related Disorders -- diagnosis
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- epidemiology
Primary Health Care
Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Chronic Disease
Comorbidity
Continuity of Patient Care
Delivery of Health Care, Integrated
HIV Infections -- prevention & control
HIV Infections -- transmission
Naloxone -- therapeutic use
Needle-Exchange Programs
Patient Care Management
Patient Care Team
Physician's Role
Prescription Drug Misuse
Humans
United States

1447. Requirements for transactions with first responders under section 582 of the Federal Food, Drug, and Cosmetic Act--compliance policy

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, February 2017
Subject(s):
Emergency Medical Services -- legislation & jurisprudence
Emergency Responders -- legislation & jurisprudence
Pharmaceutical Preparations -- supply & distribution
Drug Therapy
Legislation, Drug
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.

1448. Providing regulatory submissions in electronic format--certain human pharmaceutical product applications and related submissions using the eCTD specifications

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2017
Subject(s):
Automatic Data Processing -- standards
Investigational New Drug Application
Drug Approval -- legislation & jurisprudence
Drug Approval -- organization & administration
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.